Inhibitory effects of thioredoxin reductase antisense RNA on the growth of human hepatocellular carcinoma cells

Journal of Cellular Biochemistry

Volumn 96, Issue 3, 2005, Pages 653-664

  Gan, Lu ^a   Yang, Xiang Liang ^a   Liu, Qiong ^a   Xu, Hui Bi ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Antisense RNA; Cell cycle; Cell proliferation; Human telomerase reverse transcriptase; Telomere length; Thioredoxin reductase

Indexed keywords

COMPLEMENTARY DNA; COMPLEMENTARY RNA; DNA FRAGMENT; MESSENGER RNA; MYC PROTEIN; PROTEIN BCL 2; PROTEIN P53; THIOREDOXIN REDUCTASE;

ARTICLE; CANCER INHIBITION; CELL CYCLE; CELL CYCLE G2 PHASE; CELL GROWTH; CONTROLLED STUDY; ENZYME INHIBITION; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE CONSTRUCT; GENE INSERTION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PLASMID; PRIORITY JOURNAL; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DNA-BINDING PROTEINS; HUMANS; LIVER NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, ANTISENSE; TELOMERASE; TELOMERE; THIOREDOXIN REDUCTASE (NADPH); TUMOR SUPPRESSOR PROTEIN P53;

EID: 27144473412     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.20585     Document Type: Article

References (33)

1. Allshire RC, Dempster M, Hastie ND. 1989. Human telomeres contain at least three types of G-rice repeat distributed non-randomly. Nucleic Acids Res 17:4611-4627.
2. Andersson M, Holmgren A, Spyrou G. 1996. NK-lysin, a disulfide-containing effector peptide of T-lymphocytes, is reduced and inactivated by human thioredoxin reductase. Implication for a protective mechanism against NK-lysin cytotoxicity. J Biol Chem 271:10116-10120.
3. Berggren M, Gallegos A, Gasdaska JR, Gasdaska PY, Warneke J, Powis G. 1996. Thioredoxin reductase gene expression in human tumors and cell lines, and the effects of serum stimulation and hypoxia. Anticancer Res 16:3459-3466.
4. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
5. Choi JH, Kim TN, Kim S, Baek SH, Kim JH, Lee SR, Kim JR. 2002. Overexpression of mitochondrial thioredoxin reductase and peroxiredoxin III in hepatocellular carcinomas. Anticancer Res 22:3331-3335.
6. GasdaskaPY, Oblong JE, Cotgreave IA, Powis G. 1994. The predicted amion acid sequence of human thioredoxin is identical to that of the autocrine growth factor human adult T-cell derived factor (ADF): Thioredoxin mRNA is elevated in some human tumors. Biochim Biophys Acta 1218:292-296.
7. Gollahon LS, Shay JW. 1996. Immortalization of human mammary epithelial cells transfected with mutant p53 (273his). Oncogene 12:715-725.
8. Greider CW, Blackburn EH. 1989. A telomeric sequence in the RNA of tetrahymena telomerase required for telomere repeat synthesis. Nature 337:331-337.
9. Grundner-Culemann E, Martin GW III, Tujebajeva R, Harney JW, Berry MJ. 2001. Interplay between termination and translation machinery in eukaryotic selenoprotein synthesis. J Mol Bio 40:699-707.
10. Harley CB, Kim NW, Prowse KR, Weinrich SL, West MD, Bacchetti S, Hirte HW, Counter CM, Greider CW. 1994. Telomerase, cell immortality, and cancer. Cold Spring Harb Symp Quant Biol 59:307-315.
11. Hiyama E, Yokoyama T, Tatsumoto N, Hiyama K, Imamura Y, Murakami Y, Kodama T, Piatyszek MA, Shay JW, Matsuura Y. 1995. Telomerase activity in gastric cancer. Cancer Res 55:3258-3262.
12. Holmgren A. 1997. Bovine thioredoxin system. Purification of thioredoxin reductase from calf liver and thymus and studies of its function in disulfide reduction. J Biol Chem 252:4600-4606.
13. Hotz MA, Gong J, Traganos F, Darzynkiewicz Z. 1994. Flow cytometric detection of in situ DNA degradation and chromatin changes. Cytometry 15:237-244.
14. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, Coviello GM, Wright WE, Weinrich SL, Shay JW. 1994. Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011-2015.
15. Kitada T, Seki S, Kawatita N, Kuroki T, Monna T. 1995. Telomere shortening in chronic liver diseases. Biochem Biophys Res Commun 211:33-39.
16. Lee SR, Bar-Noy S, Kwon J, Levine RL, Stadtman TC, Rhee SG. 2000. Mammalian thioredoxin reductase: Oxidation of the C-terminal cysteine/selenocysteine active site forms a thioselenide, and replacement of selenium with sulfur markedly reduces catalytic activity. Proc Natl Acad Sci USA 97:2521-2526.
17. Liu JP. 1999. Studies of the molecular mechanism in the regulation of telomerase activity. FASEB J 13:2091-2104.
18. Massuda M, Masutani H, Nakamura H, Miyajima S, Yamauchi A, Yonehara S, Uchida A, Irimajiri K, Horiuchi A, Yodoi J. 1991. Protective activity of adult T cell leukemia-derived factor (ADF) against tumor necrosis factor-dependent cytotoxicity on U937 cells. J Immunol 147:3837-3841.
19. Meyerson M, Counter C, Eaton EN, Ellisen LW, Steiner P, Caddie SD, Ziaugra L, Beijersberger RL, Davidoff MJ, Liu Q, Bacchetti S, Haber DA, Weinberg RA. 1997. hEST2, the putative human telomerase catalytic subunit gene, is upregulated in tumor cells and during immortalization. Cell 90:785-795.
20. Mosman T. 1983. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytoxicity assays. J Immunol Methods 65:55-63.
21. Mustacich D, Powis G. 2000. Thioredoxin reductase. J Biochem 346:1-8.
22. Oblong JE, Gasdaska PY, Sherrill K, Powis G. 1993. Purification of human thioredoxin reductase: Properities and characterization by absorption and circular dichroism spectroscopy. Biochemistry 32:7271-7277.
23. Reed JC. 1994. Bcl-2 and the regulation of programmed cell death. J Cell Biol 124:1-6.
24. Rufer N, Dragowska W, Thornbury G, Roosnek E, Lansdorp PM. 1998. Telomere length dynamics in human lymphocyte subpopulations measured by flow cytometry. Nat Biotechnol 16:743-747.
25. Shi C, Yu LZ, Yang FG, Yan J, Zeng HH. 2003. A novel organoselenium compound induces cell cycle arrest and apoptosis in prostate cancer cell lines. Biochem Biophys Res Commun 309:578-583.
26. Spyrou G, Holmgren A. 1996. Deoxyribonucleoside triphosphate pools and growth of glutathione-depleted 3T6 mouse fibroblasts. Biochem Biophys Res Commun 220: 42-46.
27. Steele RJC, Thompson AM, Hall PA, Lane DP. 1998. The p53 tumor suppressor gene. Br J Surg 85:1460-1467.
28. Sun QA, Wu Y, Zappacosta F, Jeang KT, Lee BJ, Hatfield DL, Gladyshev VN. 1999. Redox regulation of cell signaling by selenocysteine in mammalian thioredoxin reductases. J Biol Chem 274:24522-24530.
29. Tamura T, Stadtman TC. 1996. A new selenoprotein from human lung adenocarcinoma cells: Purification, properties, and thioredoxin reductase activity. Proc Natl Acad Sci USA 93:1006-1011.
30. Ueda M, Ouhtit A, Bito T, Nakazawa K, Lubbe J, Ichihashi M, Yamasaki H, Nakazawa H. 1997. Evidence for UV-associated activation of telomerase in human skin. Cancer Res 57:370-374.
31. Wang SJ, Sakamoto T, Yasuda SI, Fukasawa I, Ota Y, Hayashi M, Okura T, Zheng JH, Inaba N. 2002. The relationship between telomere length and telomerase activity in Gynecologic cancers. Gynecol Oncol 84:81-84.
32. Wu QZ, Huang KX, Xu HB. 2003. Effects of long-term selenium deficiency on glutathione peroxidase and thioredoxin reductase activities and expressions in rat aorta. J Inorg Biochem 94:301-306.
33. Zhong L, Arner ES, Holmgren A. 2000. Structure and mechanism of mammalian thioredoxin reductase: The active site is a redox-active selenolthiol/ selenenylsulfideformed from the conserved cysteine-selenocysteine sequence. Proc Natl Acad Sci USA 97:5854-5859.